AChE-IN-8 (Compound 19) is a highly potent inhibitor of acetylcholinesterase (AChE), exhibiting an IC50 value of 1.95 μM. This compound shows promise for further investigation in the research of Alzheimer's disease [1].
AChE-IN-21 (Compound I-8) is a highly potent and selective orally active inhibitor of acetylcholinesterase (AChE). It exhibits an impressive inhibitory concentration (IC50) of 2.66 nM. Additionally, AChE-IN-21 demonstrates excellent in vitro blood-brain barrier (BBB) permeability [1].